Clinical Trial Site
Columbus, Ohio
We've found
1 trials
at this facility
Amyloidosis Clinical Trial
Updated: 12/31/1969
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials